Exercise therapy in polycystic ovary syndrome: a systematic review (Q37787632)

23 August 2017

Exercise therapy in polycystic ovary syndrome: a systematic review (English)

1 reference

polycystic ovary syndrome

23 August 2017

1 reference

1 reference

1 reference

Catherine B Lombard

2

0 references

Lisa J Moran

object named as

Lisa J Moran

series ordinal

3

0 references

Helena Teede

object named as

Helena J Teede

series ordinal

4

0 references

author name string

Cheryce L Harrison

series ordinal

1

1 reference

23 August 2017

10 September 2010

1 reference

Human Reproduction Update

23 August 2017

1 reference

23 August 2017

17

1 reference

23 August 2017

2

1 reference

23 August 2017

171-183

1 reference

Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999.

23 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Effects of exercise and nutritional counseling in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Effective Exercise Modality to Reduce Insulin Resistance in Women With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Exercise, glucose transport, and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Diet and exercise in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Exercise therapy in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Response of blood lipids to exercise training alone or combined with dietary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Endurance training improves responsiveness to insulin and modulates insulin signal transduction through the phosphatidylinositol 3-kinase/Akt-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Combined aerobic and resistance exercise improves glycemic control and fitness in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Metformin for the treatment of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Consensus on infertility treatment related to polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

The effect of combined aerobic and resistance exercise training on abdominal fat in obese middle-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Exercise as cardiovascular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Hyperlipoproteinemia, atherosclerosis risk, and dietary management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

The management of insulin resistance in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Long-term health consequences of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Obesity and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ045

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMQ045

1 reference

23 August 2017

1 reference

PubMed ID

20833639